Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Zhao J, Sun W, Chen J, Sun Z, Chen D, Cao C, Yang M, Ma J, Wang L, Xing C, Chen Y, Sheng M, Zhou E, Xu L, Gao K, Liu L, Liu Q, Yi L, He W, Zhu Y. Zhao J, et al. Among authors: xing c. Evid Based Complement Alternat Med. 2020 Oct 21;2020:4073901. doi: 10.1155/2020/4073901. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33144869 Free PMC article.
Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005.
Wang Y, Zhang L, Li X, Xu Y, Yang M, Qian J, Wang L, Chen N, Gu Y, Chen M, Xing C, Chen X, Hou F, Yu X, Cheng X, Guo L, Wei C, Huang G, Zhang Q, Wang R, Wang L, Mei C, Li Y, Liu Z, Zhao L, Wu Y, Wang HY. Wang Y, et al. Among authors: xing c. Hypertens Res. 2009 Jun;32(6):444-9. doi: 10.1038/hr.2009.38. Hypertens Res. 2009. PMID: 19494816
[Treatment of chronic primary glomerulopathy patients of Shen deficiency and dampness heat syndrome by yishen qingli granule combined low-dose Tripterygium wilfordii multiglycoside tablet: a clinical efficacy observation].
Sheng MX, Sun W, Xing CY, Yuan FH, Tang SF, Xiong PH, Ma JP, Zhou D, Gao K, Jiang Y, Chen JH, Mao HJ, Mou J, Luo YZ, Wei MG, Liu CX. Sheng MX, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Dec;33(12):1636-41. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013. PMID: 24517060 Clinical Trial. Chinese.
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Wu J, Duan SW, Yang HT, Deng YY, Li W, He YN, Ni ZH, Zhan YL, Lin S, Guo ZY, Zhu J, Fang JA, Liu XS, Wang LH, Wang R, Wang NS, Cheng XH, He LQ, Luo P, Sun SR, Sun JF, Yin AP, Jiang GR, Chen HY, Liu WH, Lin HL, Liang M, Ma L, Chen M, Song LQ, Chen J, Zhu Q, Xing CY, Li Y, Gao JN, Li RS, Li Y, Zhang H, Lu Y, Zhou QL, Fu JZ, He Q, Cai GY, Chen XM. Wu J, et al. J Integr Med. 2021 Mar;19(2):111-119. doi: 10.1016/j.joim.2021.01.009. Epub 2021 Jan 30. J Integr Med. 2021. PMID: 33589406 Free article. Clinical Trial.
2,428 results